Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury.
about
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational ProspectiveInflammation induced loss of skeletal muscleFirst Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-β Superfamily Cytokine, MIC-1/GDF15Dissecting the mechanism of carotid atherosclerosis from the perspective of regulationBiomarkers of cardiovascular stress and subclinical atherosclerosis in the community.The correlation of serum growth differentiation factor-15 level in patients with obstructive sleep apnea.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingConcise review: growth differentiation factor 15 in pathology: a clinical role?Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation.Critical appraisal of inflammatory markers in cardiovascular risk stratification.Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease.Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis.Elevated GDF-15 contributes to pulmonary inflammation upon cigarette smoke exposure.Growth differentiation factor 15 as a predictor of adverse renal outcomes in patients with immunoglobulin A nephropathy.Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro.Growth Differentiation Factor-15 and Risk of CKD Progression.Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.Repeated measurement of growth-differentiation factor-15 in Chinese Han patients with post-myocardial infarction chronic heart failure
P2860
Q26798142-4593B57B-AFE7-475C-BD2A-09737A817D4AQ28083759-9EFC4F57-F88C-4526-ABD1-3D4AB1522D6AQ30364849-17AEA745-D8DA-4EBD-A653-0916B98B7724Q34426836-B6B907B8-5207-451C-9ACC-AEFAC2B12D18Q35224090-D6393CBC-C445-4994-BA85-CB0F720149A8Q35620885-EA167749-71BF-41BA-A734-C7258A0A7303Q35640438-2C4E80D0-2137-4C74-B62A-6BAD3E9B058DQ36347479-1F21D1B6-F94C-4771-AFBD-251A57108B07Q37344271-3ECDE386-0F92-48DB-9B5D-A837045B2400Q37630908-4DC52DD3-3710-4311-A3D2-FD5F8E39DFB2Q38219501-40BEFD74-D3C3-4DEF-A04E-E7746B1ED3C9Q38671285-FD6FA3EA-7FFF-46DE-84D1-BBC162ABA17BQ42373707-C1FDA4C4-292E-4667-B0C7-29D2C750F849Q47213170-EB45820E-8787-48AA-802A-82F1EDD34844Q47985560-734FDBD3-1315-4DCD-88B5-66B47E4CFDF1Q48132987-08558D2F-126F-4EE3-80E5-61464436B718Q50149505-868B3BF8-E2F8-41FC-B975-B4F26A296492Q51153601-23104673-637E-4EE8-94AA-D421D02D68B3Q52868225-3718E2D6-3A25-4C53-B255-FCD57645B018Q58789993-BEC4EF5C-7682-42F1-B0DA-B46634F467C0
P2860
Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Growth differentiation factor- ...... y response to vascular injury.
@en
type
label
Growth differentiation factor- ...... y response to vascular injury.
@en
prefLabel
Growth differentiation factor- ...... y response to vascular injury.
@en
P2093
P2860
P356
P1476
Growth differentiation factor- ...... y response to vascular injury.
@en
P2093
Gabriel A Bonaterra
Jens Strelau
Joel Thogersen
Ralf Kinscherf
Sabrina A Walter
Stefanie Zügel
Uwe Haberkorn
P2860
P304
P356
10.1161/JAHA.112.002550
P577
2012-12-19T00:00:00Z